Neuron-glia crosstalk in health and disease: Fractalkine and CX3CR1 take centre stage

Open Biology

Volumn 3, Issue 1 DEC, 2013, Pages

  Sheridan, Graham K ^a   Murphy, Keith J ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Alzheimer's disease; CX3CR1; Fractalkine; Ischaemia; Microglia; Synaptic plasticity

Indexed keywords

CYTOKINE RECEPTOR; FRACTALKINE; V28 RECEPTOR; VIRUS RECEPTOR;

ALZHEIMER DISEASE; ANIMAL; BRAIN; CENTRAL NERVOUS SYSTEM DISEASE; CX3CR1; GLIA; HUMAN; INFLAMMATION; ISCHEMIA; LEARNING; MICROGLIA; NERVE CELL; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ALZHEIMER'S DISEASE; CX3CR1; FRACTALKINE; ISCHAEMIA; MICROGLIA; SYNAPTIC PLASTICITY;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; CHEMOKINE CX3CL1; HUMANS; INFLAMMATION; LEARNING; NEUROGLIA; NEURONAL PLASTICITY; NEURONS; RECEPTORS, CYTOKINE; RECEPTORS, HIV;

EID: 84897478440     PISSN: None     EISSN: 20462441     Source Type: Journal    
DOI: 10.1098/rsob.130181     Document Type: Review

References (120)

1. Kriegstein AR, Götz M. 2003 Radial glia diversity: a matter of cell fate. Glia 43, 37-43. (doi:10.1002/ glia.10250) (Pubitemid 36781695)
2. Paukert M, Bergles DE. 2006 Synaptic communication between neurons and NG2p cells. Curr. Opin. Neurobiol. 16, 515-521. (doi:10.1016/ j.conb.2006.08.009) (Pubitemid 44466399)
3. Nishiyama A. 2007 Polydendrocytes: NG2 cells with many roles in development and repair of the CNS. Neuroscientist 13, 62-76. (doi:10.1177/ 1073858406295586) (Pubitemid 46052754)
4. Pinto L, Götz M. 2007 Radial glial cell heterogeneity: the source of diverse progeny in the CNS. Prog. Neurobiol. 83, 2-23. (doi:10.1016/j. pneurobio.2007.02.010) (Pubitemid 47241312)
5. Kettenmann H, Verkhratsky A. 2008 Neuroglia: the 150 years after. Trends Neurosci. 31, 653-659. (doi:10.1016/j.tins.2008.09.003)
6. Verkhratsky A. 2010 Physiology of neuronal-glial networking. Neurochem. Int. 57, 332-343. (doi:10.1016/j.neuint.2010.02.002)
7. Parpura V et al. 2012 Glial cells in ( patho)physiology. J. Neurochem. 121, 4-27. (doi:10.1111/j.1471-4159.2012.07664.x)
8. Somjen GG. 1988 Nervenkitt: notes on the history of the concept of neuroglia. Glia 1, 2-9. (doi:10.1002/ glia.440010103)
9. Golgi C. 1885 Sulla fina anatomia degli organi sistema nervoso. Riv. Sper. Fremiat. Med. Leg. Alien. Ment. 11, 72-123
10. Andriezen WL. 1893 The neuroglia elements in the human brain. Br. Med. J. 2, 227-230. (doi:10.1136/ bmj.2.1700.227)
11. Ramon y Cajal S. 1909 Histologie du systeme nerveux de l'homme et des vertebres. France: Maloine
12. Kettenmann H, Hanisch U, Noda M, Verkhratsky A. 2011 Physiology of microglia. Physiol. Rev. 91, 461-553. (doi:10.1152/physrev.00011.2010)
13. Ginhoux F et al. 2010 Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845. (doi:10.1126/ science.1194637)
14. Kierdorf K et al. 2013 Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8- dependent pathways. Nat. Neurosci. 16, 273-280. (doi:10.1038/nn.3318)
15. Ransohoff RM, Perry VH. 2009 Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145. (doi:10.1146/annurev. immunol.021908.132528)
16. Ransohoff RM, Cardona AE. 2010 The myeloid cells of the central nervous system parenchyma. Nature 468, 253-262. (doi:10.1038/nature09615)
17. Nimmerjahn A, Kirchhoff F, Helmchen F. 2005 Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318. (doi:10.1126/science.1110647) (Pubitemid 40746128)
18. Hughes V. 2012 Microglia: the constant gardeners. Nature 485, 570-572. (doi:10.1038/485570a)
19. Schafer DP et al. 2012 Microglia sculpt postnatal neural circuits in an activity and complementdependent manner. Neuron 74, 691-705. (doi:10.1016/j.neuron.2012.03.026)
20. Weigert C. 1895 Beitrage zur kenntnis der normalen menshlichen neuroglia. Frankfurt, Germany: Moritz Diesterweg
21. Nedergaard M, Ransom B, Goldman SA. 2003 New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 26, 523-530. (doi:10.1016/j.tins.2003.08.008) (Pubitemid 37176906)
22. Huang YH, Sinha SR, Tanaka K, Rothstein JD, Bergles DE. 2004 Astrocyte glutamate transporters regulate metabotropic glutamate receptor-mediated excitation of hippocampal interneurons. J. Neurosci. 24, 4551-4559. (doi:10.1523/JNEUROSCI.5217- 03.2004) (Pubitemid 38656611)
23. Haydon PG, Carmignoto G. 2006 Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev. 86, 1009-1031. (doi:10.1152/physrev. 00049.2005) (Pubitemid 44033387)
24. Pascual O, Ben Achour S, Rostaing P, Triller A, Bessis A. 2012 Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc. Natl Acad. Sci. USA 109, E197-E205. (doi:10.1073/pnas.1111098109)
25. Bezzi P, Gundersen V, Galbete JL, Seifert G, Steinhäuser C, Pilati E, Volterra A. 2004 Astrocytes contain a vesicular compartment that is competent for regulated exocytosis of glutamate. Nat. Neurosci. 7, 613-620. (doi:10.1038/nn1246) (Pubitemid 38691900)
26. Domercq M, Brambilla L, Pilati E, Marchaland J, Volterra A, Bezzi P. 2006 P2Y1 receptor-evoked glutamate exocytosis from astrocytes: control by tumor necrosis factor-a and prostaglandins. J. Biol. Chem. 281, 30 684-30 696. (doi:10.1074/jbc. M606429200) (Pubitemid 44582124)
27. Jourdain P et al. 2007 Glutamate exocytosis from astrocytes controls synaptic strength. Nat. Neurosci. 10, 331-339. (doi:10.1038/nn1849)
28. Cal? C, Marchaland J, Regazzi R, Bezzi P. 2008 SDF 1-a (CXCL12) triggers glutamate exocytosis from astrocytes on a millisecond time scale: imaging analysis at the single-vesicle level with TIRF microscopy. J. Neuroimmunol. 198, 82-91. (doi:10. 1016/j.jneuroim.2008.04.015)
29. Cal? C, Bezzi P. 2010 CXCR4-mediated glutamate exocytosis from astrocytes. J. Neuroimmunol. 224, 13-21. (doi:10.1016/j.jneuroim.2010.05.004)
30. Prada I, Marchaland J, Podini P, Magrassi L, D'Alessandro R, Bezzi P, Meldolesi J. 2011 REST/NRSF governs the expression of densecore vesicle gliosecretion in astrocytes. J. Cell Biol. 193, 537-549. (doi:10.1083/ jcb.201010126)
31. Santello M, Bezzi P, Volterra A. 2011 TNFa controls glutamatergic gliotransmission in the hippocampal dentate gyrus. Neuron 69, 988-1001. (doi:10.1016/ j.neuron.2011.02.003)
32. Zlotnik A, Yoshie O. 2000 Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127. (doi:10.1016/S1074- 7613(00)80165-X) (Pubitemid 30398626)
33. Hatori K, Nagai A, Heisel R, Ryu JK, Kim SU. 2002 Fractalkine and fractalkine receptors in human neurons and glial cells. J. Neurosci. Res. 69, 418-426. (doi:10.1002/jnr.10304) (Pubitemid 34809490)
34. Harrison JK et al. 1998 Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl Acad. Sci. USA 95, 10 896-10 901. (doi:10.1073/ pnas.95.18.10896) (Pubitemid 28413165)
35. Rosténe W, Kitabgi P, Parsadaniantz S. 2007 Chemokines: a new class of neuromodulator? Nat. Rev. Neurosci. 8, 895-903. (doi:10.1038/nrn2255) (Pubitemid 350006221)
36. Lu M, Grove EA, Miller RJ. 2002 Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc. Natl Acad. Sci. USA 99, 7090-7095. (doi:10. 1073/pnas.092013799) (Pubitemid 34526260)
37. Tran PB, Miller RJ. 2003 Chemokine receptors: signposts to brain development and disease. Nat. Rev. Neurosci. 4, 444-455. (doi:10.1038/nrn1116) (Pubitemid 37280166)
38. Araujo DM, Cotman CW. 1993 Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res. 600, 49-55. (doi:10.1016/ 0006-8993(93)90400-H) (Pubitemid 23034251)
39. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. 1998 Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl Acad. Sci. USA 95, 14 500-14 505. (doi:10. 1073/pnas.95.24.14500) (Pubitemid 28549396)
40. Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH. 1998 The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J. Neurosci. 18, 10 457-10 463 (Pubitemid 29016565)
41. Bruno V, Copani A, Besong G, Scoto G, Nicoletti F. 2000 Neuroprotective activity of chemokines against N-methyl-D-aspartate or b-amyloid-induced toxicity in culture. Eur. J. Pharmacol. 399, 117-121. (doi:10.1016/S0014- 2999(00)00367-8) (Pubitemid 30407031)
42. Limatola C, Ciotti MT, Mercanti D, Vacca F, Ragozzino D, Giovannelli A, Santoni A, Eusebi F, Miledi R. 2000 The chemokine growth-related gene product b protects rat cerebellar granule cells from apoptotic cell death through a-amino-3-hydroxy-5- methyl-4-isoxazolepropionate receptors. Proc. Natl Acad. Sci. USA 97, 6197-6201. (doi:10.1073/pnas. 090105997) (Pubitemid 30367546)
43. Deiva K, Geeraerts T, Salim H, Leclerc P, Hery C, Hugel B, Freyssinet JM, Tardieu M. 2004 Fractalkine reduces N-methyl-D-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation. Eur. J. Neurosci. 20, 3222-3232. (doi:10.1111/j. 1460-9568.2004.03800.x) (Pubitemid 40013533)
44. Krathwohl MD, Kaiser JL. 2004 Chemokines promote quiescence and survival of human neural progenitor cells. Stem Cells 22, 109-118. (doi:10.1634/ stemcells.22-1-109) (Pubitemid 38018787)
45. Limatola C, Lauro C, Catalano M, Ciotti MT, Bertollini C, Di Angelantonio S, Ragozzino D, Eusebi F. 2005 Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J. Neuroimmunol. 166, 19-28. (doi:10.1016/j. jneuroim.2005.03.023) (Pubitemid 41074653)
46. Garton KJ, Gough PJ, Blobel CP, Murphy G, Greaves DR, Dempsey PJ, Raines EW. 2001 Tumor necrosis factor-a-converting enzyme (ADAM17)mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 276, 37 993-38 001. (doi:10.1074/ jbc.M106434200)
47. Cotter R, Williams C, Ryan L, Erichsen D, Lopez A, Peng H, Zheng J. 2002 Fractalkine (CX3CL1) and brain inflammation: implications for HIV-1- associated dementia. J. Neurovirol. 8, 585-598. (doi:10.1080/13550280290100950) (Pubitemid 36104722)
48. Hundhausen C et al. 2003 The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102, 1186-1195. (doi:10.1182/blood- 2002- 12-3775) (Pubitemid 36988021)
49. Clark AK et al. 2007 Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. Proc. Natl Acad. Sci. USA 104, 10 655-10 660. (doi:10.1073/pnas.0610811104) (Pubitemid 47185720)
50. Mizoue LS, Bazan JF, Johnson EC, Handel TM. 1999 Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1. Biochemistry 38, 1402-1414. (doi:10.1021/ bi9820614)
51. Chapman GA, Moores K, Harrison D, Campbell CA, Stewart BR, Strijbos PJ. 2000 Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J. Neurosci. 20, RC87
52. Haskell CA, Cleary MD, Charo IF. 1999 Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. J. Biol. Chem. 274, 10 053-10 058. (doi:10.1074/jbc.274.15.10053) (Pubitemid 29180871)
53. Hermand P, Pincet F, Carvalho S, Ansanay H, Trinquet E, Daoudi M, Combadiére C, Deterre P. 2008 Functional adhesiveness of the CX3CL1 chemokine requires its aggregation. Role of the transmembrane domain. J. Biol. Chem. 283, 30 225-30 234. (doi:10.1074/jbc.M802638200)
54. Tarozzo G, Campanella M, Ghiani M, Bulfone A, Beltramo M. 2002 Expression of fractalkine and its receptor, CX3CR1, in response to ischaemiareperfusion brain injury in the rat. Eur. J. Neurosci. 15, 1663-1668. (doi:10.1046/j.1460- 9568.2002. 02007.x) (Pubitemid 35471922)
55. Chandrasekar B, Mummidi S, Perla RP, Bysani S, Dulin NO, Liu F, Melby PC. 2003 Fractalkine (CX3CL1) stimulated by nuclear factor kB (NF-kB)- dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem. J. 373, 547-558. (doi:10.1042/BJ20030207) (Pubitemid 36897857)
56. Zujovic V, Benavides J, Vige X, Carter C, Taupin V. 2000 Fractalkine modulates TNF-a secretion and neurotoxicity induced by microglial activation. Glia 29, 305-315. (doi:10.1002/(SICI)1098-1136(20000 215)29:4,305::AID-GLIA2.3. 0.CO;2-V) (Pubitemid 30121421)
57. Mattison HA, Nie H, Gao H, Zhou H, Hong JS, Zhang J. 2013 Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice. J. Neuroimmunol. 257, 110-115. (doi:10.1016/j. jneuroim.2013.02.008)
58. Maciejewski-Lenoir D, Chen S, Feng L, Maki R, Bacon KB. 1999 Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J. Immunol. 163, 1628-1635 (Pubitemid 29352788)
59. Meucci O, Fatatis A, Simen AA, Miller RJ. 2000 Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc. Natl Acad. Sci. USA 97, 8075-8080. (doi:10.1073/ pnas.090017497) (Pubitemid 30460775)
60. Hughes PM, Botham MS, Frentzel S, Mir A, Perry VH. 2002 Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 327, 314-327. (doi:10.1002/glia.10037)
61. Tarozzo G, Bortolazzi S, Crochemore C, Chen SC, Lira AS, Abrams JS, Beltramo M. 2003 Fractalkine protein localization and gene expression in mouse brain. J. Neurosci. Res. 73, 81-88. (doi:10.1002/jnr.10645) (Pubitemid 36791372)
62. Verge GM, Milligan ED, Maier SF, Watkins LR, Naeve GS, Foster AC. 2004 Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur. J. Neurosci. 20, 1150-1160. (doi:10.1111/j.1460-9568.2004.03593.x) (Pubitemid 39233569)
63. Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J, Ji RR. 2007 Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain. Behav. Immun. 21, 642-651. (doi:10.1016/j.bbi.2006.11.003) (Pubitemid 46830963)
64. Heinisch S, Kirby LG. 2009 Fractalkine/CX3CL1 enhances GABA synaptic activity at serotonin neurons in the rat dorsal raphe nucleus. Neuroscience 164, 1210-1223. (doi:10.1016/ j.neuroscience.2009.08.075)
65. Rolstad B, Giaidt A. 1998 MIP-3a, MIP-3b and fractalkine induce the locomotion and the mobilization of intracellular calcium and activate the heterotrimeric G proteins in human natural killer cells. Immunology 8, 618-624. (doi:10.1046/j. 1365-2567.1998.00603.x) (Pubitemid 28559156)
66. Lyons A, Lynch AM, Downer EJ, Hanley R, O'Sullivan JB, Smith A, Lynch MA. 2009 Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro. J. Neurochem. 110, 1547-1556. (doi:10.1111/j.1471-4159.2009.06253.x)
67. O'Sullivan NC, Sheridan GK, Murphy KJ. 2012 Transcriptional profiling of hippocampal memory- associated synaptic plasticity: old friends and new faces. In Transcription factors CREB and NF-kB: involvement in synaptic plasticity and memory formation, pp. 43-65. Sharjah, UAE: Bentham Science
68. Hua JY, Smith SJ. 2004 Neural activity and the dynamics of central nervous system development. Nat. Neurosci. 7, 327-332. (doi:10.1038/nn1218) (Pubitemid 38429168)
69. Paolicelli RC et al. 2011 Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456-1458. (doi:10. 1126/science.1202529)
70. Lauro C, Catalano M, Trettel F, Mainiero F, Ciotti MT, Eusebi F, Limatola C. 2006 The chemokine CX3CL1 reduces migration and increases adhesion of neurons with mechanisms dependent on the b1 integrin subunit. J. Immunol. 177, 7599-7606 (Pubitemid 44846274)
71. Hoshiko M, Arnoux I, Avignone E, Yamamoto N, Audinat E. 2012 Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex. J. Neurosci. 32, 15 106-15 111. (doi:10.1523/ JNEUROSCI.1167-12.2012)
72. Bertollini C, Ragozzino D, Gross C, Limatola C, Eusebi F. 2006 Fractalkine/CX3CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacology 51, 816-821. (doi:10.1016/j. neuropharm.2006.05.027) (Pubitemid 44286937)
73. Ragozzino D, Di Angelantonio S, Trettel F, Bertollini C, Maggi L, Gross C, Charo IF, Limatola C, Eusebi F. 2006 Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons. J. Neurosci. 26, 10 488- 10 498. (doi:10.1523/JNEUROSCI.3192-06.2006) (Pubitemid 44564599)
74. Piccinin S, Di Angelantonio S, Piccioni A, Volpini R, Cristalli G, Fredholm BB, Limatola C, Eusebi F, Ragozzino D. 2010 CX3CL1-induced modulation at CA1 synapses reveals multiple mechanisms of EPSC modulation involving adenosine receptor subtypes. J. Neuroimmunol. 224, 85-92. (doi:10.1016/j. jneuroim.2010.05.012)
75. Maggi L, Scianni M, Branchi I, D'Andrea I, Lauro C, Limatola C. 2011 CX(3)CR1 deficiency alters hippocampal-dependent plasticity phenomena blunting the effects of enriched environment. Front. Cell. Neurosci. 5, 22. (doi:10.3389/fncel.2011.00022)
76. Rogers JT, Morganti JM, Bachstetter AD, Hudson CE, Peters MM, Grimmig BA, Weeber EJ, Bickford PC, Gemma C. 2011 CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J. Neurosci. 31, 16 241-16 250. (doi:10.1523/JNEUROSCI.3667-11.2011)
77. Turrigiano GG. 2008 The self-tuning neuron: synaptic scaling of excitatory synapses. Cell 135, 422-435. (doi:10.1016/j.cell.2008.10.008)
78. Maggi L, Trettel F, Scianni M, Bertollini C, Eusebi F, Fredholm BB, Limatola C. 2009 LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R). J. Neuroimmunol. 215, 36-42. (doi:10.1016/j.jneuroim.2009.07.016)
79. Lauro C, Di Angelantonio S, Cipriani R, Sobrero F, Antonilli L, Brusadin V, Ragozzino D, Limatola C. 2008 Activity of adenosine receptors type 1 is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J. Immunol. 180, 7590-7596
80. Scianni M, Antonilli L, Chece G, Cristalli G, Di Castro MA, Limatola C, Maggi L. 2013 Fractalkine (CX3CL1) enhances hippocampal N-methyl-D-aspartate receptor (NMDAR) function via d-serine and adenosine receptor type A2 (A2AR) activity. J. Neuroinflammation 10, 108. (doi:10.1186/ 1742-2094-10-108)
81. Huang YY, Colino A, Selig DK, Malenka RC. 1992 The influence of prior synaptic activity on the induction of long-term potentiation. Science 255, 730-733. (doi:10.1126/science.1346729)
82. Izumi Y, Clifford DB, Zorumski CF. 1992 Low concentrations of N-methyl-D-aspartate inhibit the induction of long-term potentiation in rat hippocampal slices. Neurosci. Lett. 137, 245-248. (doi:10.1016/0304-3940(92) 90414-3)
83. Drapeau E, Mayo W, Aurousseau C, Le Moal M, Piazza PV, Abrous DN. 2003 Spatial memory performances of aged rats in the water maze predict levels of hippocampal neurogenesis. Proc. Natl Acad. Sci. USA 100, 14 385-14 390. (doi:10.1073/pnas.2334169100) (Pubitemid 37499246)
84. Luo CX, Jiang J, Zhou QG, Zhu XJ, Wang W, Zhang ZJ, Han X, Zhu DY. 2007 Voluntary exercise-induced neurogenesis in the postischemic dentate gyrus is associated with spatial memory recovery from stroke. J. Neurosci. Res. 85, 1637-1646. (doi:10.1002/jnr.21317) (Pubitemid 46849611)
85. Kee N, Teixeira CM, Wang AH, Frankland PW. 2007 Preferential incorporation of adult-generated granule cells into spatial memory networks in the dentate gyrus. Nat. Neurosci. 10, 355-362. (doi:10. 1038/nn1847)
86. Jessberger S, Clark RE, Broadbent NJ, Clemenson GD, Consiglio A, Lie DC, Squire LR, Gage FH. 2009 Dentate gyrus-specific knockdown of adult neurogenesis impairs spatial and object recognition memory in adult rats. Learn. Mem. 16, 147-154. (doi:10.1101/lm.1172609)
87. Bachstetter AD, Morganti JM, Jernberg J, Schlunk A, Staten H. 2011 Fractalkine and CX(3)CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol. Aging 32, 2030-2044. (doi:10.1016/j. neurobiolaging.2009.11. 022)
88. Tsou CL, Haskell CA, Charo IF. 2001 Tumor necrosis factor-a-converting enzyme mediates the inducible cleavage of fractalkine. J. Biol. Chem. 276, 44 622-44 626. (doi:10.1074/jbc. M107327200)
89. Pabon MM, Bachstetter AD, Hudson CE, Gemma C, Bickford PC. 2011 CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease. J. Neuroinflammation 8, 9. (doi:10.1186/ 1742-2094-8-9)
90. Roseti C et al. 2013 Fractalkine/CX3CL1 modulates GABAA currents in human temporal lobe epilepsy. Epilepsia 54, 1834-1844. (doi:10.1111/epi.12354)
91. Perry VH, Nicoll JAR, Holmes C. 2010 Microglia in neurodegenerative disease. Nat. Rev. Neurol. 6, 193-201. (doi:10.1038/nrneurol.2010.17)
92. Cardona AE et al. 2006 Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9, 917-924. (doi:10.1038/nn1715) (Pubitemid 43980506)
93. Mizuno T, Kawanokuchi J, Numata K, Suzumura A. 2003 Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res. 979, 65-70. (doi:10.1016/S0006-8993(03)02867-1) (Pubitemid 36798062)
94. Soriano SG et al. 2002 Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J. Neuroimmunol. 125, 59-65. (doi:10.1016/ S0165-5728(02)00033-4) (Pubitemid 34327454)
95. Cipriani R et al. 2011 CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J. Neurosci. 31, 16 327-16 335. (doi:10.1523/ JNEUROSCI.3611-11.2011)
96. Lambertsen KL et al. 2009 Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J. Neurosci. 29, 1319-1330. (doi:10.1523/ JNEUROSCI.5505-08.2009)
97. Denes A, Ferenczi S, Halasz J, Környei Z, Kovacs KJ. 2008 Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse. J. Cereb. Blood Flow Metab. 28, 1707-1721. (doi:10.1038/jcbfm.2008.64)
98. Pimentel-Coelho PM, Michaud JP, Rivest S. 2013 Evidence for a gender-specific protective role of innate immune receptors in a model of perinatal brain injury. J. Neurosci. 33, 11 556-11 572. (doi:10.1523/JNEUROSCI. 0535-13.2013)
99. Sospedra M, Martin R. 2005 Immunology of multiple sclerosis. Annu. Rev. Immunol. 23, 683-747. (doi:10.1146/annurev.immunol.23. 021704.115707) (Pubitemid 40563183)
100. Lassmann H, van Horssen J, Mahad D. 2012 Progressive multiple sclerosis: pathology and pathogenesis. Nat. Rev. Neurol. 8, 647-656. (doi:10.1038/nrneurol. 2012.168)
101. Baxter AG. 2007 The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 7, 904-912. (doi:10.1038/ nri2190) (Pubitemid 350006239)
102. Constantinescu CS, Farooqi N, O'Brien K, Gran B. 2011 Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br. J. Pharmacol. 164, 1079-1106. (doi:10.1111/ j.1476-5381.2011.01302.x)
103. Sunnemark D, Eltayeb S, Nilsson M, Wallström E, Lassmann H, Olsson T, Berg AL, Ericsson-Dahlstrand A. 2005 CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. J. Neuroinflammation 2, 17. (doi:10.1186/1742-2094-2-17) (Pubitemid 41529028)
104. Schwaeble WJ et al. 1998 Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Lett. 439, 203-207. (doi:10.1016/S0014-5793(98)01384-2) (Pubitemid 28546645)
105. Pan Y et al. 1997 Neurotactin, a membraneanchored chemokine upregulated in brain inflammation. Nature 387, 611-617. (doi:10. 1038/42491) (Pubitemid 27248766)
106. Garcia JA, Pino PA, Mizutani M, Cardona SM, Charo IF, Ransohoff RM, Forsthuber TG, Cardona AE. 2013 Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation. J. Immunol. 191, 1063-1072. (doi:10.4049/ jimmunol.1300040)
107. Stojkovic L, Djuric T, Stankovic A, Dinc?ic E, Stanc?ic O, Veljkovic N, Alavantic D, Zivkovic M. 2012 The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis. J. Neuroimmunol. 245, 87-92. (doi:10.1016/j. jneuroim.2011.12.028)
108. Thuret S, Moon LDF, Gage FH. 2006 Therapeutic interventions after spinal cord injury. Nat. Rev. Neurosci. 7, 628-643. (doi:10.1038/nrn1955) (Pubitemid 44106745)
109. Shechter R et al. 2009 Infiltrating blood-derived macrophages are vital cells playing an antiinflammatory role in recovery from spinal cord injury in mice. PLoS Med. 6, e1000113. (doi:10.1371/journal.pmed.1000113)
110. Silver J, Miller JH. 2004 Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146-156. (doi:10.1038/nrn1326) (Pubitemid 38160289)
111. Donnelly DJ, Longbrake EE, Shawler TM, Kigerl KA, Lai W, Tovar CA, Ransohoff RM, Popovich PG. 2011 Deficient CX3CR1 signaling promotes recovery after mouse spinal cord injury by limiting the recruitment and activation of Ly6Clo/iNOSp macrophages. J. Neurosci. 31, 9910-9922. (doi:10.1523/JNEUROSCI. 2114-11.2011)
112. Querfurth HW, LaFerla FM. 2010 Alzheimer's disease. N. Engl. J. Med. 362, 329-344. (doi:10. 1056/NEJMra0909142)
113. Huang Y, Mucke L. 2012 Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204-1222. (doi:10.1016/j.cell.2012.02.040)
114. Mandrekar S, Landreth GE. 2010 Microglia and inflammation in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 9, 156-167. (doi:10.2174/ 187152710791012071)
115. Lee CYD, Landreth GE. 2013 The role of microglia in amyloid clearance from the AD brain. J. Neural. Transm. 117, 949-960. (doi:10.1007/s00702- 010-0433-4)
116. Giulian D, Haverkamp LJ, Yu JH, Karshin W, Tom D, Li J, Kirkpatrick J, Kuo LM, Roher AE. 1996 Specific domains of b-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16, 6021-6037 (Pubitemid 26313978)
117. Fuhrmann M et al. 2010 Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat. Neurosci. 13, 411-413. (doi:10.1038/nn.2511)
118. Wu J, Bie B, Yang H, Xu JJ, Brown DL, Naguib M. 2013 Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency. Neurobiol. Aging 34, 2843-2852. (doi:10.1016/j. neurobiolaging.2013.06.003)
119. Tuppo EE, Arias HR. 2005 The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell Biol. 37, 289-305. (doi:10.1016/j.biocel.2004.07.009) (Pubitemid 39330191)
120. Duan RS, Yang X, Chen ZG, Lu MO, Morris C, Winblad B, Zhu J. 2008 Decreased fractalkine and increased IP-10 expression in aged brain of APP(swe) transgenic mice. Neurochem. Res. 33, 1085-1089. (doi:10.1007/s11064-007-9554-z)